Relevant bibliographies by topics / Drug delivery to brain

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Drug delivery to brain'

Author: Grafiati
Published: 28 June 2021
Last updated: 29 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drug delivery to brain.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drug delivery to brain"

1

Vohra, Manisha, Mohammad Amir, Amit Sharma, and Sheetu Wadhwa. "Formulation Strategies for Nose-to-Brain Drug Delivery." Journal of Pharmaceutical Technology, Research and Management 10, no. 1 (2022): 87–102. http://dx.doi.org/10.15415/jptrm.2022.101008.

Full text
Abstract:
Background: Neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Dementia, and others are becoming more common globally due to people’s changing lifestyles. Furthermore, the presence of the Blood-Brain barrier and other limitations of oral and other routes of administration makes drug delivery to the brain somewhat tricky. As a result, numerous novel drug delivery systems are being developed for drug administration to the brain. However, nose-to-brain administration is one of the most effective, safe, and non-invasive methods. Purpose: To discuss no
APA, Harvard, Vancouver, ISO, and other styles
2

Pawar, Bhakti, Nupur Vasdev, Tanisha Gupta, et al. "Current Update on Transcellular Brain Drug Delivery." Pharmaceutics 14, no. 12 (2022): 2719. http://dx.doi.org/10.3390/pharmaceutics14122719.

Full text
Abstract:
It is well known that the presence of a blood–brain barrier (BBB) makes drug delivery to the brain more challenging. There are various mechanistic routes through which therapeutic molecules travel and deliver the drug across the BBB. Among all the routes, the transcellular route is widely explored to deliver therapeutics. Advances in nanotechnology have encouraged scientists to develop novel formulations for brain drug delivery. In this article, we have broadly discussed the BBB as a limitation for brain drug delivery and ways to solve it using novel techniques such as nanomedicine, nose-to-br
APA, Harvard, Vancouver, ISO, and other styles
3

Sanjib, Bahadur, Naurange Tripti, Baghel Pragya, Sahu Manisha, and Yadu Kamesh. "Targeting the brain: various approaches and science involved." ScienceRise: Pharmaceutical Science, no. 5(27) (October 30, 2020): 4–16. https://doi.org/10.15587/2519-4852.2020.210824.

Full text
Abstract:
The brain targeting drug delivery system is the technique and process to deliver the drug into brain or central nerves system (CNS). The main problem arise during brain targeting in case of several brain related diseases and disorders such as CNS malignancy, brain abscess, multiple sclerosis, schizophrenia etc. selective and limiting permeation nature of barriers i.e. blood brain barrier (BBB) and blood cerebrospinal fluid barrier (BCSF), these two barriers only allow highly lipophilic molecule enters into brain and is one of the greatest clinical impediment of treatment of brain and CNS disea
APA, Harvard, Vancouver, ISO, and other styles
4

Pawar, Rohan. "Nose to Brain Drug Delivery System." International Journal for Research in Applied Science and Engineering Technology 12, no. 3 (2024): 2412–37. http://dx.doi.org/10.22214/ijraset.2024.59316.

Full text
Abstract:
Abstract: The treatment of brain disorders is particularly challenging due to the presence of a variety of formidable obstacles to deliver drugs selectively and effectively to the brain. Blood-brainbarrier (BBB) constitutes the major obstacle to the uptake of drugs into the brain following systemic administration. Intranosedelivery offers a non-invasive and convenient method to bypass the BBB and delivery of therapeutics directly to the brain. The review discusses the potential of intranoseroute to deliver drugs to the brain, the mechanisms and pathways of direct nose to brain drug transport,
APA, Harvard, Vancouver, ISO, and other styles
5

Chahar, Rajeev Kumar, Chanchal Tiwari, Princy Malik, and PANKAJ KUMAR JAISWAL. "Brain-Targeted Drug Delivery System: A Novel Approach." Journal of Drug Delivery and Therapeutics 12, no. 6 (2022): 171–78. http://dx.doi.org/10.22270/jddt.v12i6.5776.

Full text
Abstract:
A targeted drug delivery system is based on a technique that continuously administers a predetermined dosage of a therapeutic agent to a sick location of the body. The targeted drug delivery goal is to raise the relative amount of the treatment in the target tissues while lowering it in the non-target tissues. This technique's intrinsic benefit has been reduced drug dose and adverse effects. Drug targeting in the brain is one of the most challenging issues in pharmaceutical research because the blood-brain barrier acts as an impermeable barrier for systemically delivered therapeutics and the b
APA, Harvard, Vancouver, ISO, and other styles
6

Dilip, Kumar Uikey, and Maroti Shende Shubham. "Review on brain-targeted drug delivery." World Journal of Advanced Research and Reviews 18, no. 3 (2023): 1489–94. https://doi.org/10.5281/zenodo.8435901.

Full text
Abstract:
Brain-targeted drug delivery is a field of research that seeks to develop new methods for delivering drugs to the brain. This is done by overcoming the blood-brain barrier (BBB), a network of cells that tightly regulate the flow of substances between the blood and the brain. Most of the time lipophilic drugs are easily cross blood brain barrier but few of them less soluble in lipid therefore they don’t cross the blood brain barrier. After review we concluded that we can easily improve the solubility of drug using various techniques and Brain-targeted drug delivery is a promising field of
APA, Harvard, Vancouver, ISO, and other styles
7

Nguyen, Thi-Thao-Linh, and Van-An Duong. "Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery." Pharmaceuticals 18, no. 5 (2025): 615. https://doi.org/10.3390/ph18050615.

Full text
Abstract:
In recent decades, nose-to-brain drug delivery has shown effectiveness in treating many central nervous system diseases. Intranasally administered drugs can be delivered to the brain through the olfactory and trigeminal pathways that bypass the blood–brain barrier. However, nose-to-brain drug delivery is challenging due to the inadequate nasal mucosa absorption of drugs and the short retention time of the intranasal formulations. These problems can be minimized through the use of nano-drug delivery systems, such as micelles, polymeric nanoparticles, nanoemulsions, liposomes, solid lipid nanopa
APA, Harvard, Vancouver, ISO, and other styles
8

Dasgupta, Ankur. "Nanotechnology based Drug Delivery for Brain Targeting." International Journal for Research in Applied Science and Engineering Technology 12, no. 1 (2024): 328–29. http://dx.doi.org/10.22214/ijraset.2024.57931.

Full text
Abstract:
Abstract: Nanotechnology is an excellent and evolving technology that can be used in the field of healthcare, engineering, environmental science, etc. There is a protective barrier around the brain called the blood brain barrier (BBB) which prevents the entry of larger molecules inside the brain, maintaining brain homeostasis and this poses as a problem because the drugs implemented during any CNS disorder cannot reach the brain. Nanoparticles are solid particles that range from 1-100nm in diameter and are used as a carrier for drug delivery. Nanoparticles are used because of their various cha
APA, Harvard, Vancouver, ISO, and other styles
9

Bahadur, Shiv, Nidhi Sachan, Ranjit K. Harwansh, and Rohitas Deshmukh. "Nanoparticlized System: Promising Approach for the Management of Alzheimer’s Disease through Intranasal Delivery." Current Pharmaceutical Design 26, no. 12 (2020): 1331–44. http://dx.doi.org/10.2174/1381612826666200311131658.

Full text
Abstract:
Alzheimer's disease (AD) is a neurodegenerative brain problem and responsible for causing dementia in aged people. AD has become most common neurological disease in the elderly population worldwide and its treatment remains still challengeable. Therefore, there is a need of an efficient drug delivery system which can deliver the drug to the target site. Nasal drug delivery has been used since prehistoric times for the treatment of neurological disorders like Alzheimer's disease (AD). For delivering drug to the brain, blood brain barrier (BBB) is a major rate limiting factor f
APA, Harvard, Vancouver, ISO, and other styles
10

A, Sharma. "Macrophage Backpacks: A Novel Strategy for Targeted Brain Drug Delivery." Nanomedicine & Nanotechnology Open Access 9, no. 4 (2024): 1–2. https://doi.org/10.23880/nnoa-16000338.

Full text
Abstract:
The blood-brain barrier (BBB) is a highly selective and protective barrier that separates the brain from the circulatory system. It is composed of tightly packed endothelial cells that prevent most molecules from entering the brain. While this barrier is essential for maintaining the brain’s homeostasis, it also poses a significant challenge for drug delivery to the brain. Most therapeutics are unable to cross the BBB, which limits their efficacy in treating brain diseases. Therefore, there is a need for innovative drug delivery systems that can bypass the BBB and deliver therapeutics to the b
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Drug delivery to brain"

1

Boltman, Taahirah. "Liposomal drug delivery to brain cancer cells." University of the Western Cape, 2015. http://hdl.handle.net/11394/4706.

Full text
Abstract:
Master of Science (Nanoscience)<br>Neuroblastomas (NBs) are the most common solid extra-cranial tumours diagnosed in childhood and characterized by a high risk of tumour relapse. Like in other tumour types, there are major concerns about the specificity and safety of available drugs used for the treatment of NBs, especially because of potential damage to the developing brain. Many plant-derived bioactive compounds have proved effective for cancer treatment but are not delivered to tumour sites in sufficient amounts due to compromised tumour vasculature characterized by leaky capillary walls. B
APA, Harvard, Vancouver, ISO, and other styles
2

Huynh, Grace. "Convection administered drug delivery to the brain." Diss., Search in ProQuest Dissertations & Theses. UC Only, 2007. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3251934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lungare, Shital. "Development of novel delivery systems for nose-to-brain drug delivery." Thesis, Aston University, 2017. http://publications.aston.ac.uk/37491/.

Full text
Abstract:
The blood brain barrier (BBB) poses a significant hurdle to brain drug delivery. However, the location of the olfactory mucosa, within the nasal cavity, is a viable target site for direct nose-to-brain (N2B) delivery, thereby bypassing the BBB. To exploit this target site innovative nasal formulations are required for targeting and increasing residency within the olfactory mucosa. We developed and characterised three formulation systems for N2B delivery, (i) thermoresponsive mucoadhesion nasal gels sprays; (ii) mesoporous silica nanoparticles and (iii) nasal pMDI devices. We developed an optim
APA, Harvard, Vancouver, ISO, and other styles
4

Charlton, Stuart Thomas. "Drug delivery to the brain via intranasal administration." Thesis, University of Nottingham, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.275962.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ibegbu, Madu Daniel. "Functionalised dextran nanoparticles for drug delivery to the brain." Thesis, University of Portsmouth, 2015. https://researchportal.port.ac.uk/portal/en/theses/functionalised-dextran-nanoparticles-for-drug-delivery-to-the-brain(c2da4093-315e-4647-90e1-4340acf2b8bd).html.

Full text
Abstract:
Towards the development of drug carriers that are capable of crossing the Blood Brain Barrier, the techniques of emulsion polymerisation and nanoprecipitation have been utilised to produce nanoparticulate carriers from a systematic series of alkylglyceryl dextrans (of two different average molecular weights, 6 kDa and 100 kDa) that had been functionalised with ethyl and butyl cyanoacrylates. Also, zero length grafting of polylactic acid to butyl, octyl and hexadecylglyceryl dextrans has allowed the preparation of polylactic acid-functionalised nanoparticles. All materials and derived nanoparti
APA, Harvard, Vancouver, ISO, and other styles
6

Bin, Bostanudin Mohammad Fauzi. "Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain." Thesis, University of Portsmouth, 2016. https://researchportal.port.ac.uk/portal/en/theses/butylglycerylmodified-polysaccharide-nanoparticles-for-drug-delivery-to-the-brain(a91de9ba-3070-40a4-bf66-400f4d63027d).html.

Full text
Abstract:
The limited access to the brain of a large number of therapeutic actives due to the presence of the blood-brain barrier (BBB) has led to intensive research toward the development of nanotechnology-based approaches. Polysaccharides such as chitosan, guar gum, pectin and pullulan have been selected as starting materials for this study due to their biocompatibility, biodegradability, good drug carrier properties, and ease of chemical modification with short chain alkylglycerol-like moieties (expected to enhance drug permeability through the BBB). A series of butylglyceryl-modified polysaccharides
APA, Harvard, Vancouver, ISO, and other styles
7

Ong, Qunya. "Local drug delivery for treatment of brain tumor associated edema." Thesis, Massachusetts Institute of Technology, 2014. http://hdl.handle.net/1721.1/95865.

Full text
Abstract:
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2014.<br>Cataloged from PDF version of thesis.<br>Includes bibliographical references (pages 115-127).<br>Brain tumor associated edema, a common feature of malignant brain neoplasms, is a significant cause of morbidity from brain tumor. Systemic administration of corticosteroids, the standard of care, is highly effective but can introduce serious systemic complications. Agents that inhibit the vascular endothelial growth factor (VEGF) pathway, such as cediranib, are promising alternatives, but are also associated with syste
APA, Harvard, Vancouver, ISO, and other styles
8

Sharma, Gitanjali. "Dual Modified Liposomes for Drug and Gene Delivery to Brain." Diss., North Dakota State University, 2014. https://hdl.handle.net/10365/27310.

Full text
Abstract:
The overall goal of our research was to design a vector for efficient delivery of therapeutic genes/drugs to brain. Specifically, this research work was focused on designing PEGylated liposomes surface modified with the receptor targeting protein, transferrin and cell penetrating peptides (CPPs) for targeting and improving the delivery of desired therapeutic agent to brain. Various CPPs including poly-L-arginine, TAT, Penetratin and Mastoparan were investigated for their influence on transport of transferrin receptor targeted liposomes across brain endothelial cells. The dual-modified liposome
APA, Harvard, Vancouver, ISO, and other styles
9

Toman, Petr. "Nanoparticles from alkylglyceryl-modified polysaccharides for drug delivery to the brain." Thesis, University of Portsmouth, 2012. https://researchportal.port.ac.uk/portal/en/theses/nanoparticles-from-alkylglycerylmodified-polysaccharides-for-drug-delivery-to-the-brain(7c977729-1e45-45d9-b826-f1729a8d784c).html.

Full text
Abstract:
The loading of therapeutic actives into polymeric nanoparticles represents one of the approaches towards drug transport through the blood-brain barrier – the main obstacle to drug delivery into the central nervous system. The non-toxic, biocompatible and biodegradable polysaccharides chitosan and dextran were modified with permeation-enhancing alkylglyceryl pendant chains through reaction with epoxide precursors. The modified polysaccharides were characterised by spectroscopic methods (1H-, 13C-NMR and FT-IR). These polysaccharides were further formulated into nanoparticles using three methods
APA, Harvard, Vancouver, ISO, and other styles
10

Molnár, Éva. "Modified-chitosan nanoparticles for drug delivery through the blood-brain barrier." Thesis, University of Portsmouth, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.494005.

Full text
Abstract:
Towards the development of nanoparticulate carriers that cross the blood-brain barrier, a series of alkylglyceryl-modified chitosans with systematically varied degrees of grafting were prepared through synthetic steps that involved the protection of amino moieties via the formation of phthaloyl chitosan. The modified chitosans were formulated into nanoparticle using an ionic gelation technique employing sodium tripolyphosphate. Polymers were characterised by FTER, ¹H- and ¹³C-NMR, and by viscometry and GPC techniques. The size distribution profiles of nanoparticles were determined by dynamic l
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Drug delivery to brain"

1

de Lange, Elizabeth C. M., Margareta Hammarlund-Udenaes, and Robert G. Thorne, eds. Drug Delivery to the Brain. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-88773-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Morales, Javier O., and Pieter J. Gaillard, eds. Nanomedicines for Brain Drug Delivery. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-0838-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hammarlund-Udenaes, Margareta, Elizabeth C. M. de Lange, and Robert G. Thorne, eds. Drug Delivery to the Brain. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-9105-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kumar Singh, Anurag, Vivek K. Chaturvedi, and Jay Singh. Nanoarchitectonics for Brain Drug Delivery. CRC Press, 2024. http://dx.doi.org/10.1201/9781032661964.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Agrahari, Vivek, Anthony Kim, and Vibhuti Agrahari, eds. Nanotherapy for Brain Tumor Drug Delivery. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1052-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mishra, Neeraj, Sumel Ashique, Ashish Garg, Vadivalagan Chithravel, and Krishnan Anand, eds. Exosomes Based Drug Delivery Strategies for Brain Disorders. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-8373-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hammarlund-Udenaes, Margareta, Elizabeth C. M. de Lange, and Robert G. Thorne. Drug delivery to the brain: Physiological concepts, methodologies, and approaches. Edited by American Association of Pharmaceutical Scientists. AAPS Press, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ebrahimi, Meysam. Nano Drug Delivery to Brain Cancer: Medicine to help treat cancer. LAP LAMBERT Academic Publishing, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

L, Domellöf, ed. Drug delivery in cancer treatment III: Home care--symptom control, economy, brain tumours. Springer-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

G, De Boer A., ed. Drug tranport(ers) and the diseased brain: Proceedings of the Esteve Foundation Symposium 11, held between 6 and 9 October 2004, S'Agaró (Girona), Spain. Elsevier, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Drug delivery to brain"

1

Potschka, Heidrun. "Targeting the Brain – Surmounting or Bypassing the Blood–Brain Barrier." In Drug Delivery. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-00477-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mamada, Sukamto S., Mirnawati Salampe, Rohit Sharma, Achmad Himawan, and Firzan Nainu. "Brain Diseases." In Nanoarchitectonics for Brain Drug Delivery. CRC Press, 2024. http://dx.doi.org/10.1201/9781032661964-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

O’Reilly, Meaghan A., and Kullervo Hynynen. "Ultrasound and Microbubble-Mediated Blood-Brain Barrier Disruption for Targeted Delivery of Therapeutics to the Brain." In Targeted Drug Delivery. Springer US, 2018. http://dx.doi.org/10.1007/978-1-4939-8661-3_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hynynen, Kullervo. "Macromolecular Delivery Across the Blood–Brain Barrier." In Macromolecular Drug Delivery. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-429-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Durgun, Meltem Ezgi, Gamze Çamlık, İsmail Tuncer Değim, and Yıldız Özsoy. "Nose-to-Brain Delivery of Peptides and Proteins." In Nasal Drug Delivery. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23112-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Guarnieri, Michael, Benjamin S. Carson, and George I. Jallo. "Catheters for Chronic Administration of Drugs into Brain Tissue." In Drug Delivery Systems. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-210-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pardridge, William M. "Strategies for Drug Delivery through the Blood-Brain Barrier." In Directed Drug Delivery. Humana Press, 1985. http://dx.doi.org/10.1007/978-1-4612-5186-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Govender, Mershen, Sunaina Indermun, Pradeep Kumar, and Yahya E. Choonara. "Potential Targeting Sites to the Brain Through Nasal Passage." In Nasal Drug Delivery. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23112-4_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

De La Fuente, Maria, Maria V. Lozano, Ijeoma F. Uchegbu, and Andreas G. Schätzlein. "Chapter 7.3. Drug Delivery Strategies: Nanostructures for Improved Brain Delivery." In Drug Discovery. Royal Society of Chemistry, 2012. http://dx.doi.org/10.1039/9781849735292-00392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Huile Gao and Xinguo Jiang. "Brain Delivery Using Nanotechnology." In Blood-Brain Barrier in Drug Discovery. John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118788523.ch24.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Drug delivery to brain"

1

Wei, Mian, and Wei Min. "Single-particle imaging of nanomedicine crossing the blood-brain barrier." In Optical Molecular Probes, Imaging and Drug Delivery. Optica Publishing Group, 2025. https://doi.org/10.1364/omp.2025.om5e.1.

Full text
Abstract:
Current understanding of nanocarrier-brain interaction remains elusive. Based on stimulated Raman scattering, we develop an optical method for imaging nanocarriers in brain tissue with single-particle sensitivity, chemical specificity, and particle counting capability.
APA, Harvard, Vancouver, ISO, and other styles
2

Han, Qinghua, David R. Brenes, Jonathan T. C. Liu, Suzie Pun, Nathan White, and Drew L. Sellers. "Analyzing drug delivery and efficacy in a murine model of traumatic brain injury imaged with 3D open-top light-sheet microscopy (Conference Presentation)." In Visualizing and Quantifying Drug Distribution in Tissue IX, edited by Conor L. Evans and Kin Foong Chan. SPIE, 2025. https://doi.org/10.1117/12.3044612.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Quispe, Rodrigo, Jorge A. Trevino, Faizan Khan, and Vera Novak. "Strategies for nose-to-brain drug delivery." In the 8th International Workshop on Innovative Simulation for Healthcare. CAL-TEK srl, 2019. http://dx.doi.org/10.46354/i3m.2019.iwish.017.

Full text
Abstract:
"Intranasal drug administration is an effective method that has shown promise for delivering drugs directly to the brain. This approach is associated with many challenges, and efficacy in bypassing blood-brain barrier (BBB) is debated. This review describes the pathways of nose-to-brain drug delivery, physicochemical drug properties that influence drug uptake through the nasal epithelium, physiological barriers, methods to enhance nose-to-brain absorption, drug bioavailability and biodistribution, and intranasal devices for nose-to-brain drug delivery. The mechanism of each device is described
APA, Harvard, Vancouver, ISO, and other styles
4

Ergin, Aysegul, Mei Wang, Shailendra Joshi, and Irving J. Bigio. "Optical Monitoring of Tracers and Mitoxantrone in Rabbit Brain and the Variability in Blood-Brain Barrier Disruption." In Optical Molecular Probes, Imaging and Drug Delivery. OSA, 2011. http://dx.doi.org/10.1364/omp.2011.omc3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Seekell, Kevin C., Spencer Lewis, Christy Wilson, Gerald Grant, and Adam P. Wax. "Feasibility of Brain Tumor Delineation using Immunolabeled Gold Nanorods." In Optical Molecular Probes, Imaging and Drug Delivery. OSA, 2013. http://dx.doi.org/10.1364/omp.2013.mw1c.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chandra, D., and P. Karande. "Transferrin mediated drug delivery to brain." In 2011 37th Annual Northeast Bioengineering Conference (NEBEC). IEEE, 2011. http://dx.doi.org/10.1109/nebc.2011.5778697.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

DePaoli, Damon, Nicolas Lapointe, Younès Messaddeq, Martin Parent, and Daniel C. Côté. "Primate brain tissue identification using a compact coherent Raman spectroscopy probe." In Optical Molecular Probes, Imaging and Drug Delivery. OSA, 2019. http://dx.doi.org/10.1364/omp.2019.ow4d.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gradinaru, Viviana. "Visualizing the Activity and Anatomy of Brain Circuits: Optogenetic Sensors and Tissue Clearing Approaches." In Optical Molecular Probes, Imaging and Drug Delivery. OSA, 2015. http://dx.doi.org/10.1364/omp.2015.jw2b.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gerega, Anna, Wojciech Weigl, Daniel Milej, et al. "Multiwavelength time-resolved measurement of diffuse reflectance for brain oxygenation assessment during hypoxic challenge test." In Optical Molecular Probes, Imaging and Drug Delivery. OSA, 2011. http://dx.doi.org/10.1364/omp.2011.omc4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sui, Kunyang, Marcello Meneghetti, Jaspreet Kaur, Jakob Fleng Sørensen, Rune W. Berg, and Christos Markos. "Microstructured soft fiber-based neural device for drug delivery and optical neuromodulation." In Optics and the Brain. Optica Publishing Group, 2022. http://dx.doi.org/10.1364/brain.2022.bw4c.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Drug delivery to brain"

1

Choi, Hannah. The Review of Central Nervous System Drug Delivery Through the Blood Brain Barrier using Nanoparticles for Treatment of Brain Diseases. Iowa State University, 2023. http://dx.doi.org/10.31274/cc-20240624-1482.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thayumanavan, Sankaran. Feedback Drug Delivery Vehicles. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada577627.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Anderson, Burt, Richard Heller, Ed Turos, and Mark Mclaughlin. Drug Discovery, Design and Delivery. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada563482.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Agarwal, Jayant P., and Himanshu J. Sant. Drug Delivery for Peripheral Nerve Regeneration. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada613477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Orwin, Elizabeth, Isabella Wulur, Nicole Esclamado, and Madineh Sarvestani. Cell Delivery System for Traumatic Brain Injury. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada482999.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kannavou, Maria, Kanelina Karali, Theodora Katsila, et al. BNN27 nanoformulations for nose-to-brain delivery. Peeref, 2023. http://dx.doi.org/10.54985/peeref.2306p3373108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dotto, Gian P. Peptide-Targeted Drug Delivery to Breast Tumors. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada373913.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Atif Syed, Atif Syed. Targeted Drug Delivery by using Magnetic Nanoparticles. Experiment, 2013. http://dx.doi.org/10.18258/0788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dotto, Gian P. Peptide-Targeted Drug Delivery to Breast Tumors. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada392787.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Esenaliev, Rinat O. Novel Drug Delivery Technique for Breast Cancer Therapy. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada410175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Drug delivery to brain' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography